We are live on ! Find out more
CAM

Cormorant Asset Management Portfolio holdings

AUM $1.95B
1-Year Est. Return 773.9%
This Fund
S&P 500
This Quarter Est. Return
+17.24%
1 Year Est. Return
+773.9%
3 Year Est. Return
+3,976.92%
5 Year Est. Return
+17,750.67%
10 Year Est. Return
+592,782.78%
AUM
$345M
AUM Growth
–
Cap. Flow
+$314M
Cap. Flow %
91.14%
Top 10 Hldgs %
62.86%
Holding
37
New
37
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$33M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$25.9M
3
DYAX
DYAX CORPORATION
DYAX
+$21.6M
4
KERX
Keryx Biopharmaceuticals Inc
KERX
+$20.3M
5
CELG
Celgene Corp
CELG
+$19M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 65.39%
2 Miscellaneous 34.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMRX
26
DELISTED
Chimerix, Inc.
CMRX
$2.16M 0.63%
+143,000
New +$2.28M
BCRX icon
27
BioCryst Pharmaceuticals
BCRX
$2.15B
$2.04M 0.59%
+268,000
New +$1.7M
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.93M 0.56%
+75,000
New +$1.82M
OSIR
29
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$1.73M 0.5%
+107,800
New +$1.72M
XNPT
30
DELISTED
XENOPORT, INC.
XNPT
$1.15M 0.33%
+200,000
New +$1.08M
RGLS
31
DELISTED
Regulus Therapeutics
RGLS
$739K 0.21%
+833
New +$717K
MNTA
32
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$490K 0.14%
+27,700
New +$465K
PTCT icon
33
PTC Therapeutics
PTCT
$5.64B
$489K 0.14%
+28,800
New +$506K
DNDN
34
DELISTED
DENDREON CORPORATION
DNDN
$449K 0.13%
+150,000
New +$422K
FPRX
35
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$336K 0.1%
+20,000
New +$249K
ENTA icon
36
Enanta Pharmaceuticals
ENTA
$370M
$273K 0.08%
+10,000
New +$242K
1
2

Similar funds

AHC
Adell Harriman & Carpenter Houston, Texas $1.95B AUM 52.72% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.95B AUM 25.88% 1-Year Est. Return
BFPW
BOK Financial Private Wealth Denver, Colorado $1.95B AUM 20.52% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.95B AUM 42.71% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Cormorant Asset Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Cormorant Asset Management, which disclosed 37 positions worth $345M. Its ten largest holdings account for 63% of the portfolio.

Its largest position is MEDIVATION, INC.: 1,093,800 shares worth $34.9M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, followed by Miscellaneous.

  • Cormorant Asset Management's largest Q4 2013 buy was MEDIVATION, INC.: 1,093,800 shares worth $34.9M.
  • Cormorant Asset Management's ten largest holdings make up 63% of its $345M portfolio in Q4 2013.
  • Cormorant Asset Management disclosed 37 positions in Q4 2013, its first 13F filing on record.

Based on Cormorant Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.